Histopathological evaluation of liver fibrosis and cirrhosis regression
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The hepatic repair complex in the setting of cirrhosis has received increasing attention, as it implies the regression of cirrhosis, which was traditionally taken to be an irreversible state. In this brief review, the patterns of fibrosis, the existing staging systems for chronic liver disease and the histopathological features of cirrhosis regression are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“For example the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) histologic scoring system includes stages 1A and 1B for zone 3 fibrosis while also providing a stage 1C for pediatric-type fibrosis.(13) The Congestive Hepatic Fibrosis score is another example where stage 1 refers to zone 3 fibrosis.”
MethodNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“0078 alcoholic liver disease or adult non-alcoholic fatty liver disease, fibrosis starts with a centrilobular perivenular distribution and sinusoidal fibrosis.(5,6) The fibrosis pattern in pediatric fatty liver disease is similar to that observed in hepatotropic virus infection featuring a periportal distribution, whi…”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 2×
“Upon chronic liver injury, hepatic stellate cells are activated and transformed into a myofibroblast-like phenotype to lay down extracellular matrix.(3) Well-characterized stimuli to stellate cells include chronic inflammation, cytokine production by injured parenchymal cells, and disruption of extracellular matrix.”
BackgroundMarcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Clinical evidence for the regression of liver fibrosis
Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Akkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
“While no drug has as yet been approved for the treatment of liver fibrosis, some novel treatment approaches have been shown to be effective in patients with chronic viral hepatitis that were successfully treated with antivirals [58,199].”
BackgroundLiver fibrosis assessment: MR and US elastography
Ozturk, A., Olson, M. C., Samir, A. E., & Venkatesh, S. K. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03269-4 · Cited by 168
Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice
Luo, S., Zhao, X., Jiang, J., Deng, B., Liu, S., Xu, H., Tan, Q., Chen, Y., Zhang, Z., Pan, X., et al. (2023) · Theranostics · doi:10.7150/thno.86103 · Cited by 76
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
Metadata
- Authors
- Lo, R. C., & Kim, H.
- Venue
- Clinical and Molecular Hepatology
- Published
- 2017-12-25
- Volume
- 23
- Issue
- 4
- Pages
- 302-307
- ISSN
- 2287-2728 (ISSN-L)
- 2287-285X
- OpenAlex
- W2776677355
- Cited by
- 151
- References
- 5
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histopathological evaluation of liver fibrosis and cirrhosis regression. https://app.cochat.ai/papers/10.3350/cmh.2017.0078
- The paper
- Lo, R. C., & Kim, H. (2017). Histopathological evaluation of liver fibrosis and cirrhosis regression. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2017.0078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.